FBInvestor
Stocks / Dexcom Inc
Institutional Ownership

Dexcom Inc

CUSIP 252131107COMDXCMQ1 2026

13D / 13G Filings
26
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
12.6%
Max % of class reported
Institutional Holders
942
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

26 filings · latest Oct 30, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Oct 30, 2025The Vanguard Group13G/A12.6%49.46MSEC
2Apr 24, 2025Blackrock, Inc.13G/A8.3%32.50MSEC
3Dec 6, 2024Blackrock, Inc.13G/A10.4%40.45MSEC
4Feb 13, 2024Vanguard Group Inc13G/A11.5%44.47MSEC
5Jan 25, 2024Blackrock Inc.13G/A8.5%32.85MSEC
6Feb 10, 2023Blackrock Inc.13G/A8.7%33.54MSEC
7Feb 9, 2023Vanguard Group Inc13G/A11.3%43.82MSEC
8Jan 27, 2023Blackrock Inc.13G/A8.7%33.88MSEC
9Jan 25, 2023Blackrock Inc.13G/A8.8%33.88MSEC
10Feb 9, 2022Vanguard Group Inc13G/A10.7%10.41MSEC

16 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Dexcom Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →